Compass Therapeutics Engages Investors with December Events
BOSTON - Compass Therapeutics, Inc. (Nasdaq: CMPX), a company renowned for its clinical-stage oncology efforts, is excited to announce its participation in upcoming significant investor events this December. As a biopharmaceutical company developing innovative antibody-based therapeutics, Compass aims to foster deeper connections with investors and share its ongoing developments in treating various human diseases.
Details of Upcoming Events
Among the highlighted events, Compass will be attending...
Piper Sandler 37th Annual Healthcare Conference
This esteemed conference will take place in New York. Attendees can catch Compass's informative session on Tuesday at 8:00 AM ET. The event promises engaging insights into the company’s strategic innovations in oncology, particularly in proprietary therapeutics.
8th Annual Evercore Healthcare Conference
Following closely, the Evercore Healthcare Conference in Coral Gables will occur on December 4, starting at 10:00 AM ET. This event will provide an excellent platform for Compass to showcase its advancements and future research directions in the oncology field.
Replay Options and One-on-One Meetings
For those unable to attend the live presentations, Compass will offer access to archived sessions for 90 days through their events page. This flexibility allows investors to delve into significant discussions regarding ongoing projects and the future of oncology therapeutics.
Management will also be available for personalized meetings during all events. Interested investors are encouraged to reach out to their representatives to schedule these discussions and explore their inquiries first-hand.
About Compass Therapeutics
Compass Therapeutics focuses on cutting-edge research and clinical development aimed at tackling cancer through proprietary antibody-based treatments. The company's unique approach synthesizes insights into the immune system's role in tumor growth and introduces agents that target angiogenesis, thus disrupting the vital processes that allow tumors to thrive.
With a robust pipeline dedicated to enhancing immune responses and countering tumor evasion strategies, Compass Therapeutics demonstrates its commitment to innovation in the oncology space. Planned advancements include clinical trials involving a combination of therapies designed to synergistically amplify anti-tumor responses.
Founded recently, Compass Therapeutics operates from Boston, where it continually channels its resources into refining these groundbreaking treatments. Its dedication to translating scientific discoveries into impactful therapies reflects the company’s role as a pioneer in this critical health sector.
To learn more about Compass Therapeutics and its ongoing projects, visit https://www.compasstherapeutics.com.
Investor Contact
If you wish to get in touch with the investor relations team, please contact ir@compasstherapeutics.com.
Media Contact
For media inquiries, reach out to Anna Gifford, Chief of Staff, via email at media@compasstherapeutics.com or by phone at 617-500-8099.
Frequently Asked Questions
What is the focus of Compass Therapeutics?
Compass Therapeutics is focused on developing antibody-based therapeutics aimed at treating cancer and other diseases.
When and where are the investor events taking place?
The investor events are scheduled for December 2 in New York and December 4 in Coral Gables.
Are the presentations available for replay?
Yes, the presentations will be archived for 90 days on Compass's events page for those who cannot attend live.
How can investors schedule one-on-one meetings?
Investors should contact their respective representatives to request one-on-one meetings during the events.
Where can I find more information about Compass Therapeutics?
For further details about Compass Therapeutics and its projects, visit their official website.